Back to Search
Start Over
Persistent low prevalence of hepatitis B vaccination among people with HIV: Time for a change?
- Source :
-
Journal of Viral Hepatitis . Oct2023, Vol. 30 Issue 10, p790-792. 3p. - Publication Year :
- 2023
-
Abstract
- Hepatitis B virus (HBV) infection is one of the leading causes of hepatocellular carcinoma and mortality among people living with HIV (PLWH). HBV vaccination provides protection from infection; however, vaccination rates are low. We conducted a retrospective analysis at three HIV centres in Texas to determine the proportion of PLWH who received the recommended 3 doses of hepatitis B vaccine within 1 year. Factors associated with vaccination completion were explored. In our sample of three sites in a state with high HIV transmission and high rates of liver disease from 2011 to 2021, showed low rates of hepatitis B vaccination. Among eligible PLWH, only 9% completed the 3‐dose hepatitis B vaccine series in 1 year. There is an urgent need to improve HBV vaccination to reach 2030 target for hepatitis B elimination. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 13520504
- Volume :
- 30
- Issue :
- 10
- Database :
- Academic Search Index
- Journal :
- Journal of Viral Hepatitis
- Publication Type :
- Academic Journal
- Accession number :
- 172022198
- Full Text :
- https://doi.org/10.1111/jvh.13868